Haleon

Last updated

Haleon plc
Company type Public limited company
ISIN GB00BMX86B70
Industry
Predecessors
Founded18 July 2022;2 years ago (2022-07-18)
Headquarters Weybridge, England, United Kingdom
Area served
Worldwide
Key people
Products
Brands
RevenueIncrease2.svg £11,302 million (2023) [1]
Increase2.svg £1,996 million (2023) [1]
Decrease2.svg £1,111 million (2023) [1]
Total assets Decrease2.svg £34,055 million (2023) [1]
Total equity Increase2.svg £16,729 million (2023) [1]
Number of employees
24,000 (2023) [2]
Website www.haleon.com

Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. [3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. [4] The company was projected to be a global leader in over the counter medicines with a 7.3 percent market share in 2022. [5]

Contents

Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6]

Sir Dave Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020. [5]

History

GSK and Pfizer merged their consumer healthcare businesses in 2019. [8] [9] GSK owned just over two thirds of the joint venture, and Pfizer held the remainder. [8]

GSK announced plans to spin off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division". [10]

Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected. [11] Nestlé examined the possibility of a bid in conjunction with Reckitt. [12]

In October 2023, GSK reduced its ownership share in Haleon to just over 7.4%, [13] and again in January 2024 down to 4.2%. [14]

The Lamisil antifungal brand was sold to Karo Healthcare AB for £235 million in August 2023; the transaction was completed in November 2023. [15] [16]

The ChapStick lip care brand was sold to Yellow Wood Partners for £401 million in 2024. [17]

In March 2024, Pfizer reduced its stake in Haleon from 32% to 24% by selling 630 million shares in a public offering. [18]

In April 2024 Haleon announced that it planned to close its factory in Maidenhead. [19] Toothpaste manufacturing would be relocated to Slovakia, with mouthwash production outsourced to a third-party. [20]

In September 2024, the company completed the sale of its non-US Nicotine Replacement Therapy business to Dr. Reddy's Laboratories in a deal worth £458 million. [21]

Operations

Oral health accounted for 28.5 percent of revenue in 2021. [22]

Brands

A selection of Aquafresh toothpaste and toothbrushes produced by Haleon Aquafresh - GSK.jpg
A selection of Aquafresh toothpaste and toothbrushes produced by Haleon

Current

Brands include: [23]

  • Abreva (Docosanol)
  • Advil (Ibuprofen)
  • alli (Orlistat)
  • Anadin (pain relief)
  • Aquafresh (oral healthcare)
  • Astring-o-Sol (oral healthcare)
  • Be-Total (leader in vitamins market in Italy)
  • Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
  • Biotene (oral healthcare)
  • Boost (nutritional)
  • Breathe Right (respiratory)
  • Centrum (vitamins and naturals)
  • Cetebe (vitamins and naturals)
  • Chlorhexamed (oral healthcare)
  • Cholinex (analgesics and respiratory tract)
  • Citrucel (gastrointestinal)
  • Coldrex (cold and flu treatment)
  • Commit Lozenge (smoking cessation)
  • Committed Quitters (nicotine replacement)
  • Corega (oral healthcare)
  • Corsodyl (oral healthcare)
  • Crocin (analgesics and respiratory tract)
  • Dr. Best (oral healthcare)
  • Emergen-C
  • ENO (gastrointestinal)
  • Eumovate (dermatological)
  • Excedrin
  • Fenistil
  • Fenbid (analgesics and respiratory tract)
  • Flonase (fluticasone propionate)
  • Foodles (noodles), origin: India
  • Formigran (analgesic/triptan)
  • Grand-PA (headache/toothache/pain and fever)
  • Hinds (dermatological)
  • Junior Horlicks (nutritional)
  • Imedeen
  • Iodex (pain relief)
  • Iodosan (cold and flu treatment)
  • Macleans (oral healthcare)
  • Maltova (nutritional)
  • Maxinutrition (nutritional)
  • Med-Lemon (hot, cold and flu medication)
  • Medacalm (vitamins and naturals)
  • Nexium Control (esomeprazole)
  • Nicorette (nicotine replacement)
  • Night Nurse (cold and flu remedy)
  • NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
  • Odol (oral healthcare)
  • Odol-med3 (oral healthcare)
  • Os-cal (oral healthcare)
  • Otrivin/Otrivine (xylometazoline)
  • Panadeine (analgesics and respiratory tract)
  • Panadol/Panodil (analgesics and respiratory tract)
  • parodontax (oral healthcare)
  • Piriton/Piriteze/Pirinase (anti-allergy)
  • Polident (oral healthcare)
  • Poligrip Ultra (oral healthcare)
  • Robitussin (respiratory)
  • Rutinoscorbin (vitamins and naturals)
  • Scott's Emulsion (vitamins and naturals)
  • Sensodyne (oral healthcare)
  • Shumitect (oral healthcare)
  • Solpadeine (analgesics and respiratory tract)
  • Super Poligrip (oral healthcare)
  • Super Wernet's (oral healthcare)
  • Synthol (oral healthcare)
  • Theraflu (Respiratory)
  • Tums (gastrointestinal)
  • Viva (vitamins and naturals), origin: Nepal
  • Voltaren/Voltarol (anti inflammatory)
  • Zovirax (dermatological)

Divested

  • ChapStick (sold to Yellow Wood Partners in 2024)
  • Lamisil (terbinafine) (sold to Karo Healthcare in 2023)
  • Nicotinell (sold to Dr Reddy's Laboratories in 2024)

Related Research Articles

<span class="mw-page-title-main">Ribena</span> Blackcurrant-based drink

Ribena is a brand of blackcurrant-based soft drink, and fruit drink concentrate designed to be mixed with water. It is available in bottles, cans and multi-packs. Originally of English origin, it was produced by the pharmaceutical company GlaxoSmithKline (GSK) until 2013, when the brand was sold to Japanese beverage conglomerate Suntory.

<span class="mw-page-title-main">GSK plc</span> British pharmaceutical and biotechnology company

GSK plc is a British multinational pharmaceutical and biotechnology company with headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

<span class="mw-page-title-main">Horlicks</span> Sweet malted milk hot drink powder

Horlicks is a British sweet malted milk hot drink powder developed by founders James and William Horlick. It was first sold as "Horlick's Infant and Invalids Food", soon adding "aged and travellers" to their label. In the early 20th century, it was sold as a powdered meal replacement drink mix.

<span class="mw-page-title-main">Advil</span> An American brand of Ibuprofen

Advil is primarily a brand of ibuprofen. Advil has been called a "megabrand" because it offers various "products for a wide range of pain, head cold, and sleep problems."

<span class="mw-page-title-main">ChapStick</span> Brand name of lip balm

ChapStick is a brand name of lip balm owned by Suave Brands Company and is used in many countries worldwide. It is intended to help treat and prevent chapped lips, hence the name. Many varieties also include sunscreen to avoid sunburn.

<span class="mw-page-title-main">Liniment</span> Ointment-like medicated topical preparation for application to skin

Liniment, also called embrocation and heat rub, is a medicated topical preparation for application to the skin. Some liniments have a viscosity similar to that of water; others are lotion or balm; still, others are in transdermal patches, soft solid sticks, and sprays. Liniment usually is rubbed into the skin, which the active ingredients penetrate.

<span class="mw-page-title-main">Cefuroxime axetil</span> Chemical compound

Cefuroxime axetil, sold under the brand name Ceftin among others, is a second generation oral cephalosporin antibiotic.

<span class="mw-page-title-main">Chattem</span> American healthcare product company

Chattem, Inc. is an American, Chattanooga, Tennessee-based, producer and marketer of over-the-counter healthcare products, toiletries, dietary supplements, topical analgesics, and medicated skin care products. Originally named the Chattanooga Medicine Company, the company’s brand portfolio holds twenty-two brands including Allegra, Gold Bond, Flexall, IcyHot, Rolaids, Sun-In, Pamprin, Dexatrim, Aspercreme, and Selsun Blue. The company produces two-thirds of its products at its Chattanooga production facilities with the remaining produced by third-party producers. The company is a subsidiary of the French multinational pharmaceutical company Sanofi.

Actifed is a registered trademark for a combination antihistamine and nasal decongestant medication used for cold and allergy symptoms. Actifed was developed in 1958 by Burroughs Wellcome & Company, later Haleon.

Emergen-C is an effervescent, powdered drink mix vitamin supplement manufactured by Alacer Corp. The Emergen-C product line was introduced in 1978. Alacer was established as a private company in 1972, focusing on vitamin supplements containing vitamin C. The company was acquired by Pfizer in 2012. In 2019, Pfizer consumer healthcare entered a joint venture with GSK. The brand is owned by Haleon since 18 July 2022.

Caltrate is a brand name calcium supplement sold by Haleon.

<span class="mw-page-title-main">Sensodyne</span> Dental hygiene product for sensitive teeth

Sensodyne is a brand name of toothpaste and mouthwash targeted at people with sensitive teeth. Sensodyne is owned by Haleon and is marketed under the name Shumitect in Japan.

<span class="mw-page-title-main">Centrum (multivitamin)</span> Brand of multivitamins

Centrum is an American brand of multivitamins produced by Haleon. It was designed by Dr. Ellenbogen's team, working at Lederle Laboratories, and was introduced in 1978. It has been owned by Wyeth, Pfizer, GSK., and now Haleon.

Imedeen is a beauty supplements company that sells nutricosmetics. It was developed in the 1980s by the Swedish biochemist Ake Dahlgren. The brand is owned by Haleon and headquartered in Brentford, Hounslow a suburb in the United Kingdom.

<span class="mw-page-title-main">Wyeth</span> American pharmaceutical company

Wyeth Pharmaceuticals Inc. was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.

The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of APIs locally produced. Pakistani pharmaceutical companies are engaged in importing raw materials, compounding APIs with excipients, coating of pills, and fill-finish activities. The industry is regulated by the Drug Regulatory Authority of Pakistan, which oversees drug approvals and pricing.

Ibuprofen/paracetamol, sold under the brand name Combogesic among others, is a fixed-dose combination of two medications, ibuprofen, a non-steroidal anti-inflammatory drug (NSAID); and paracetamol (acetaminophen), an analgesic and antipyretic. It is available as a generic medication.

<span class="mw-page-title-main">Emma Walmsley</span> British businesswoman

Dame Emma Natasha Walmsley is the chief executive officer (CEO) of GSK plc. She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. She grew up in Barrow-in-Furness, Cumbria, England.

A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year.

References

  1. 1 2 3 4 5 "Annual results 2023" (PDF). Haleon. Archived (PDF) from the original on 29 February 2024. Retrieved 29 February 2024.
  2. "Haleon plots massive layoffs in UK and beyond to save costs: report". Fierce Pharma. 13 July 2023. Retrieved 11 February 2024.
  3. "GSK announces independent Consumer Healthcare company is to be called Haleon | GSK". www.gsk.com. 22 February 2022. Archived from the original on 21 February 2023. Retrieved 21 February 2023.
  4. Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times . Archived from the original on 5 August 2023. Retrieved 4 July 2022.
  5. 1 2 Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes . Archived from the original on 11 February 2023. Retrieved 10 June 2022.
  6. "Prospectus" (PDF). GSK plc. p. 15. Archived from the original (PDF) on 1 June 2022. Retrieved 10 June 2022.
  7. Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News . Archived from the original on 11 February 2023. Retrieved 10 June 2022.
  8. 1 2 Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN . Archived from the original on 6 June 2023. Retrieved 10 June 2022.
  9. "Haleon Won't Indemnify Pfizer, GSK Over Zantac. Shares Are Up". Barron's. 20 September 2022. Archived from the original on 10 November 2022. Retrieved 17 December 2022.
  10. Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters . Archived from the original on 22 September 2022. Retrieved 10 June 2022.
  11. Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian . Archived from the original on 18 October 2022. Retrieved 10 June 2022.
  12. "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News . 25 May 2022. Archived from the original on 30 April 2023. Retrieved 10 June 2022.
  13. "GSK raises $1.1 billion from Haleon stake sale". Reuters. 6 October 2023. Archived from the original on 7 October 2023. Retrieved 9 October 2023.
  14. "GSK raises $1.24 bln from latest Haleon stake sale". Reuters. 17 January 2024. Retrieved 18 January 2024.
  15. Healthcare, Karo (2 August 2023). "Karo Healthcare acquires the Global OTC brand Lamisil® from Haleon". Karo Healthcare. Archived from the original on 5 June 2024. Retrieved 5 June 2024.
  16. Healthcare, Karo (1 November 2023). "Karo Healthcare completes the acquisition of the rights to the Global OTC brand Lamisil® from Haleon". Karo Healthcare. Archived from the original on 5 June 2024. Retrieved 5 June 2024.
  17. Williams, Holly (25 January 2024). "Haleon offloads ChapStick lip balm brand in £401m deal". The Standard. Archived from the original on 20 February 2024. Retrieved 20 February 2024.
  18. "Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%". Yahoo Finance. 18 March 2024. Archived from the original on 19 March 2024. Retrieved 19 March 2024.
  19. Briant, Nathan (30 April 2024). "Sensodyne maker set to cut 435 jobs". BBC News. Archived from the original on 8 May 2024. Retrieved 8 May 2024.
  20. Mathews, Eva (30 April 2024). "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. Retrieved 8 May 2024.
  21. "Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio". Press Trust of India . Business Standard. 30 September 2024. Archived from the original on 29 October 2024. Retrieved 25 November 2024.
  22. "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. 6 January 2022. Archived from the original on 29 March 2023. Retrieved 10 June 2022.
  23. "Our Consumer Healthcare Brands". Haleon. Archived from the original on 2 August 2023. Retrieved 19 July 2022.